These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 2192289
21. Opportunities for the development of specific therapeutic agents to treat emphysema. Cohen AB. Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114 [No Abstract] [Full Text] [Related]
22. Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin. Galdston M, Melnick EL, Goldring RM, Levytska V, Curasi CA, Davis AL. Am Rev Respir Dis; 1977 Nov; 116(5):837-46. PubMed ID: 303486 [No Abstract] [Full Text] [Related]
23. Alpha-1-antitrypsin and other proteinase inhibitors. Miravitlles M. Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503 [Abstract] [Full Text] [Related]
24. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction. Abboud RT, Rushton JM, Grzybowski S. Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728 [Abstract] [Full Text] [Related]
25. Alpha 1-proteinase inhibitor for alpha 1-antitrypsin deficiency. Med Lett Drugs Ther; 1988 Mar 11; 30(761):29-30. PubMed ID: 3257810 [No Abstract] [Full Text] [Related]
26. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis]. Fal A. Wiad Lek; 1992 Mar 11; 45(5-6):233-9. PubMed ID: 1455869 [Abstract] [Full Text] [Related]
27. [Alpha 1-antitrypsin deficiency and chronic aspecific respiratory pathology (evaluation of the risk in the heterozygote state)]. Marsico SA, Cantatore D, Gennarelli E. Arch Monaldi; 1981 Mar 11; 36(3):119-30. PubMed ID: 6756332 [No Abstract] [Full Text] [Related]
28. Leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha-1-antitrypsin deficiency. Abboud RT. Am Rev Respir Dis; 1980 Nov 11; 122(5):807-8. PubMed ID: 6969564 [No Abstract] [Full Text] [Related]
29. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough. Balbi B, Ferrarotti I, Miravitlles M. Eur Respir J; 2016 Jan 11; 47(1):35-8. PubMed ID: 26721962 [No Abstract] [Full Text] [Related]
30. Proteases and antiproteases in the lung. Am Rev Respir Dis; 1983 Feb 11; 127(2):S1-58. PubMed ID: 6338778 [No Abstract] [Full Text] [Related]
31. [Proteolytic enzymes and their inhibitors in the development of destructive processes in lung diseases]. Kubyshkin AV. Sov Med; 1984 Feb 11; (9):42-6. PubMed ID: 6209806 [No Abstract] [Full Text] [Related]
32. Synthetic elastase inhibitors: prospects for use in the treatment of emphysema. Powers JC. Am Rev Respir Dis; 1983 Feb 11; 127(2):S54-8. PubMed ID: 6600895 [Abstract] [Full Text] [Related]
33. Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum. Stockley RA, Burnett D. Am Rev Respir Dis; 1979 Nov 11; 120(5):1081-6. PubMed ID: 315741 [Abstract] [Full Text] [Related]
34. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy]. Rasche B, Hochstrasser K. Prax Klin Pneumol; 1983 Oct 11; 37 Suppl 1():725-7. PubMed ID: 6557570 [No Abstract] [Full Text] [Related]
35. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. Morrison HM, Welgus HG, Stockley RA, Burnett D, Campbell EJ. Am J Respir Cell Mol Biol; 1990 Mar 11; 2(3):263-9. PubMed ID: 2310584 [Abstract] [Full Text] [Related]
36. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Abboud RT, Vimalanathan S. Int J Tuberc Lung Dis; 2008 Apr 11; 12(4):361-7. PubMed ID: 18371259 [Abstract] [Full Text] [Related]
38. [Elastase inhibitors]. Reboud-Ravaux M. J Soc Biol; 2001 Nov 11; 195(2):143-50. PubMed ID: 11723826 [Abstract] [Full Text] [Related]
39. [New possibilities in the treatment of pulmonary emphysema based on the knowledge of the pathogenetic mechanisms of this disease]. Krasucka-Kluźniak A. Pneumonol Pol; 1983 Oct 11; 51(10):531-6. PubMed ID: 6361700 [No Abstract] [Full Text] [Related]
40. [The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency]. Manresa F. Arch Bronconeumol; 1995 Oct 11; 31(7):371-2. PubMed ID: 8777536 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]